La Roche-Posay: The latest figures, news and market research on La Roche-Posay

Turnover: 1 billion EUR (2021)

Country: France

The La Roche-Posay laboratory produces and markets dermatological skincare products formulated with La Roche-Posay thermal spring water. Initially specializing in therapeutic products, the group gradually broadened its range to include daily care products, and has now turned its attention to cosmetics, while retaining its therapeutic credibility thanks to the thermal springs from which its products are derived

What sets it apart from other laboratories is the care it takes to offer products adapted to every skin type, especially highly sensitive skin, and every type of skin problem

Bought by the L'Oréal group in 1989, the La Roche-Posay laboratory is part of the ActiveCosmetics division within L'Oréal, which passed the 2 billion sales mark in 2017. This dynamism is partly due to the La Roche-Posay franchises: Effaclar, Lipikar and Cicaplast

News

"The potential of dermocosmetics is immense", says L'Oréal 11/05/2023

One in four people has a skin problem.
After the age of 60, it affects one in two.
L'Oréal's dermocosmetics division posted sales of 5 billion euros, with growth of 22%.
The dermocosmetics segment represents 8% of the global beauty market, compared with 5% a few years ago.
L'Oréal's growth last year was two and a half times faster than the market.
La Roche-Posay and CeraVe are brands with sales of over €1 billion.

La Roche-Posay wants to grow by relying on dermatologists. 02/01/2023

Leader in L'Oréal's active cosmetics division
Strong organic growth for several years
Leader in dermo-cosmetics brands
100 clinical studies by 2022
Two billion people worldwide suffer from skin problems
The L'Oréal group's cosmetics division achieved sales of €3.9 billion in 2021
In China, it will launch a premium regenerative medicine range in a year's time

The company is currently distributed in 52 countries and is a subsidiary of the L'Oréal group. L'Oréal's active cosmetics business generates 13% of its sales on the Internet.

La Roche-Posay benefits from its parent company's strategy of working in partnership with dermatologists to develop products that meet patients' specific needs, and asking these health professionals to recommend them. La Roche-Posay products are aimed primarily at people with dynamic, urban lifestyles.

Financial Data

DUNS: 306688714

Legal Name: LA ROCHE-POSAY LABORATOIRE DERMATOLOGIQUE

Address: AV RENE LEVAYER , 86270 LA ROCHE-POSAY

Number of employees: Au moins 1 salarié (2024)

Capital: 379 721 EUR

Financial Data:

Year	2022	2021	2020	2019	2018	2017	2016	2015
Turnover	-	28 703 000	24 721 000	21 710 000	19 083 729	18 868 464	17 941 791	20 371 194
Gross margin (€)	40 112 028	32 012 695	27 022 489	23 791 514	21 551 982	19 191 572	19 979 550	20 810 081
EBITDA (€)	37 149 497	29 935 773	24 755 773	21 049 719	18 172 516	16 637 427	15 063 890	14 884 289
Operating profit (€)	37 140 724	29 935 747	24 785 753	21 050 963	18 768 465	16 243 462	16 763 008	13 221 135
Net profit (€)	37 674 371	29 829 559	36 021 812	225 492 335	23 508 133	23 679 092	29 571 419	18 424 694
Turnover growth rate (%)	-100	16,1	13,9	13,8	1,1	5,2	-11,9	-
Ebitda margin rate (%)	-	104,3	100,1	97	95,2	88,2	84	73,1
Operating margin rate (%)	-	104,3	100,3	97	98,3	86,1	93,4	64,9
Working Capital (turnover days)	-	12,2	66,6	-122,9	27,4	14,4	12	-16
Working Capital requirements (turnover days)	-	29,1	27	24,6	46	32,6	24	32
Net margin (%)	-	103,9	145,7	1 038,7	123,2	125,5	164,8	90,4
Added value / Turnover (%)	-	94,2	93	89,7	92	92,8	94,2	94,8
Wages and social charges (€)	-	-1 087	-	-	704 699	866 005	1 838 679	4 336 472
Salaries / Turnover (%)	-	-	-	-	3,7	4,6	10,2	21,3